InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
T+90 hit rate
83%
T+90 mean return
+1.7%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Turner Kathy V, Vice-Présidente Senior. Officer active across 2 companies, notably Idexx Laboratories INC /de. Cumulatively, 20 reports have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €5.3m. Activity tracked since 20 May 2021. The latest transaction was filed on 29 November 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations20 total
13,838 shares0Common StockSEC:0001415889-24-028134:0
1,000 shares@ US$79.541.0% of flowCommon StockSEC:0001567619-23-003311:0
210 shares0Common StockSEC:0001567619-23-003223:0
1,000 shares@ US$79.541.0% of flowCommon StockSEC:0001567619-23-002572:0
3,000 shares@ US$141.605.6% of flowCommon StockSEC:0001567619-22-021284:0
5,310 shares@ US$206.9415.0% of flowCommon StockSEC:0001567619-22-020130:0
1,474 shares@ US$67.850.0002% mcap1.6% of flowCommon StockSEC:0001567619-22-005274:0
211 shares0Common StockSEC:0001567619-22-004787:0
1,256 shares@ US$79.540.0002% mcap1.5% of flowCommon StockSEC:0001567619-21-016671:0
1,256 shares@ US$79.541.2% of flowCommon StockSEC:0001567619-21-016671
276 shares@ US$64.240.0000% mcap0.3% of flowCommon StockSEC:0001567619-21-016516:0
2,000 shares@ US$558.44210.0017% mcap16.3% of flowCommon StockSEC:0001567619-21-016515:0
2,000 shares@ US$558.442112.6% of flowCommon StockSEC:0001567619-21-016515
276 shares@ US$64.240.2% of flowCommon StockSEC:0001567619-21-016516
2,000 shares@ US$558.44210.0017% mcap16.3% of flowCommon StockSEC:0001567619-21-011455:0
2,000 shares@ US$558.442116.3% of flowCommon StockSEC:0001567619-21-011455
900 shares@ US$549.000.0008% mcap7.2% of flowCommon StockSEC:0001567619-21-011202:0
900 shares@ US$549.007.2% of flowCommon StockSEC:0001567619-21-011202
1,000 shares@ US$535.007.8% of flowCommon StockSEC:0001567619-21-011068
1,000 shares@ US$535.000.0008% mcap7.8% of flowCommon StockSEC:0001567619-21-011068:0
20 of 20 declarations
About Turner Kathy V
Kathy V. Turner is the Senior Vice President at IDEXX LABORATORIES INC. In this role, she is responsible for the strategic and operational leadership of the company, which specializes in veterinary diagnostics. Kathy V. Turner plays a key role in managing teams and optimizing processes to ensure customer satisfaction. Her expertise in the life sciences sector is an asset to the company.
